ArticlePharmaceuticals (Basel, Switzerland)2024

Glucose-Lowering Drugs and Primary Prevention of Chronic Kidney Disease in Type 2 Diabetes Patients: A Real-World Primary Care Study.

Antonio Rodríguez-Miguel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.